ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Targeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder Cancer.

Huayuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.